"""OncoPrep validation protocol — scripting for multi-phase product efficacy validation.

Protocol: OncoPrep v1.0 — 9 Feb 2026
Phases:
    A — Standards + execution efficacy (engineering efficacy)
    B — Segmentation accuracy (scientific efficacy)
    C — Robustness and failure transparency (product robustness)
    D — Quantitative stability (downstream utility)
    E — Human factors (translation-readiness)

Reporting frameworks: CLAIM (2024), SPIRIT-AI / CONSORT-AI (if prospective).
Standards: BIDS + BIDS Derivatives.
"""
